explore -WSS

explore

author：hotspot 2025-09-08 11:04:57 - browse：6

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

leisure time

WSS

ASCO eve: Let’s set the table for this year's meeting

H5N1 virus can be tracked in retail milk, scientists say

Scrutiny of post

Where does female orgasm come from? Scientists think they know

Scrutiny of post

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

focus

explore

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Listen: More tumult at BIO & coercive care for sickle cell patients

Heart attack and stroke risk calculators need revising

Thousands protest mob assault of women who were paraded naked in remote Indian border state

23andMe had bad news about my health. I wish a person had delivered it

Clinic falsely told dozens they had Alzheimer's, suits say

Activists slam private health insurers over coverage restrictions

Transgender women dream of pregnancy via uterus transplants

Cancer drug shortages should be causing more outrage

Transgender women dream of pregnancy via uterus transplants

entertainment

PrEP can help anyone prevent HIV. Why do so few people take it?

PrEP can help anyone prevent HIV. Why do so few people take it?

Malaysia cuts short music fest after British band slams anti

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

H5N1 virus can be tracked in retail milk, scientists say

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

focus

explore

leisure time

knowledge